efavirenz and Hyperlipemia

efavirenz has been researched along with Hyperlipemia in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (20.00)	18.2507
2000's	8 (80.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohn, S; Currier, J; Koletar, S; McCutchan, J; Murphy, R; Williams, P; Wu, J	1
Boccafoglio, F; Concia, E; Gottardi, M; Lanzafame, M; Lattuada, E; Soldani, F	1
Beylot, J; Bonarek, M; Bonnet, F; De Witte, S; Morlat, P	1
Moyle, GJ	1
Calza, L; Chiodo, F; Colangeli, V; Manfredi, R; Pocaterra, D; Sebastiani, T; Tampellini, L	1
Aberg, JA; Alston, BL; Brobst, SW; Fichtenbaum, CJ; Gerber, JG; Rosenkranz, SL; Segal, Y; Vega, JM; Yang, A	1
Elliott, EB	1
Gatell, JM; Martínez, E	1
Darioli, R; Doser, N; Mooser, V; Nicod, P; Sudre, P; Telenti, A; Wietlisbach, V	1

Reviews

1 review(s) available for efavirenz and Hyperlipemia

Article	Year
NNRTI choice: has 2NN changed our practice? The AIDS reader, 2003, Volume: 13, Issue:7 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Humans; Hyperlipidemias; Nevirapine; Oxazines; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Research Design; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load	2003

Article

Year

NNRTI choice: has 2NN changed our practice?

The AIDS reader, 2003, Volume: 13, Issue:7

Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Humans; Hyperlipidemias; Nevirapine; Oxazines; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Research Design; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load

2003

Trials

4 trial(s) available for efavirenz and Hyperlipemia

Article	Year
Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution. HIV medicine, 2009, Volume: 10, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Body Fat Distribution; Cardiovascular Diseases; Coronary Disease; Cyclopropanes; Drug Therapy, Combination; Epidemiologic Methods; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Immune Reconstitution Inflammatory Syndrome; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome	2009
[Efficacy and safety of TAM-sparing antiretroviral regimens in naïve HIV-positive patients]. Le infezioni in medicina, 2009, Volume: 17, Issue:3 Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Hyperinsulinism; Hyperlipidemias; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Prospective Studies; Tenofovir; Thymidine; Treatment Outcome; Young Adult	2009
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia. AIDS (London, England), 2005, Jul-01, Volume: 19, Issue:10 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Bezafibrate; Cyclopropanes; Female; HIV Infections; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Nevirapine; Oxazines; Pravastatin; Protease Inhibitors; Reverse Transcriptase Inhibitors; Treatment Outcome	2005
Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. Journal of acquired immune deficiency syndromes (1999), 2005, Jul-01, Volume: 39, Issue:3 Topics: Adult; Alkynes; Anti-HIV Agents; Atorvastatin; Benzoxazines; Cholesterol, LDL; Cyclopropanes; Drug Interactions; Female; Heptanoic Acids; HIV Infections; HIV Seronegativity; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Oxazines; Pravastatin; Pyrroles; Simvastatin	2005

Other Studies

5 other study(ies) available for efavirenz and Hyperlipemia

Article	Year
Efavirenz-associated severe hyperlipidemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-15, Volume: 35, Issue:6 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Hyperlipidemias; Male; Oxazines	2002
Safe substitution for efavirenz. AIDS patient care and STDs, 2004, Volume: 18, Issue:1 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; HIV Infections; Humans; Hyperlipidemias; Nevirapine; Oxazines; Patient Selection; Retrospective Studies; Treatment Outcome; Viral Load	2004
Hope for HIV patients. News from the 12th International Conference on HIV and AIDS. Canadian family physician Medecin de famille canadien, 1999, Volume: 45 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Antigens; Cyclopropanes; Diet Therapy; HIV Infections; Humans; Hyperlipidemias; Oxazines	1999
[Lipodystrophy and antiretroviral agents]. Revista clinica espanola, 1999, Volume: 199, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Protease Inhibitors; HIV-1; Humans; Hyperlipidemias; Lipodystrophy; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Syndrome	1999
Persistent dyslipidemia in HIV-infected individuals switched from a protease inhibitor-containing to an efavirenz-containing regimen. Journal of acquired immune deficiency syndromes (1999), 2001, Apr-01, Volume: 26, Issue:4 Topics: Adult; Alkynes; Benzoxazines; Cyclopropanes; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Male; Oxazines; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Triglycerides	2001